Impact of different stereoisomers of inositol on insulin sensitivity of gestational diabetes mellitus patients

Table 3 Comparison of homeostasis model assessment steady state model of each group

Group		A, n = 20	B, n = 20	C, n = 20	D, n = 20	F	P value
Before treatment	HOMA-IR	8.47 ± 0.99	8.32 ± 1.01	8.51 ± 0.95	8.44 ± 0.90	0.144	0.9330
	HOMA-ISI	-4.34 ± 0.47	-4.72 ± 0.52	-4.56 ± 0.55	-4.77 ± 0.56	2.708	0.0510
After treatment	HOMA-IR	3.78 ± 0.85	3.12 ± 0.69	2.92 ± 0.53	2.85 ± 0.77	6.942	0.003
	HOMA-ISI	-0.86 ± 0.32	-0.54 ± 0.26	-0.37 ± 0.38	-0.32 ± 0.29	7.844	0.002

Data are presented as mean ± standard deviation. A: Control group; B: Myo-inositol treatment group; C: D-chiro-inositol treatment group; D: Myo-inositol + D-chiro-inositol treatment group; HOMA-IR: Homeostasis model assessment insulin resistance; HOMA-ISI: Homeostasis model assessment insulin sensitivity index.